Volume 7, Number 2—April 2001
4th Decennial International Conference on Nosocomial and Healthcare-Associated Infections
State of the Art
Molecular Approaches to Diagnosing and Managing Infectious Diseases: Practicality and Costs
|Chlamydia trachomatis detection||PCRc LCR TMA Hybrid capture||Roche Abbott Gen-Probe Digene|
|Neisseria gonorrhoeae detection||LCR Hybrid capture||Abbott Digene|
|C. trachomatis/N. gonorrhoeae screening/detection||Hybridization SDR||Gen-Probe Becton-Dickinson|
|Mycobacterium tuberculosis detection||PCR TMA||Roche Gen-Probe|
|HPV screening||Hybrid capture||Digene|
|CMV||Hybrid capture NASBA||Digene Organon Teknika|
|Grp A strep detection||Hybridization||Gen-Probe|
|Gardnerella, T. vaginalis, and Candida||Hybridization||Becton-Dickinson|
|Culture confirmation for bacteria and fungi||Hybridization||Gen-Probe|
aThe table contains examples of commercially available methods and is not intended to be all-inclusive. Websites of the principle manufacturers are a useful source of the most up-to-date information.
bCompanies: Digene, Silver Spring, MD; Chiron, Emeryville, CA; Roche, Branchburg, NJ; Organon Teknika, Durham, NC; Murex/Abbott, Abbott Park, IL; Gen-Probe, San Diego, CA; Abbott, Abbott Park, IL; Becton-Dickinson, Cockeysville, MD.
cPCR = polymerase chain reaction; LCR = ligase chain reaction; TMA = transcription-mediated amplification; SDR = strand displacement reaction; NASBA = nucleic acid strand-based amplification.
- Page created: May 10, 2011
- Page last updated: May 10, 2011
- Page last reviewed: May 10, 2011
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)